1. Alper, R.H., Hemodynamic and Renin Responses to (+−)-DOI, A Selective 5-HT2 Receptor Agonist, in Conscious Rats, Eur. J. Pharmacol., 1990, vol. 175, no. 3, pp. 323–332.
2. Appel, N.M., Track, N.S., and Van Loon, G.R., Autonomic and Endocrine Participation in Opioid Peptide-Induced Hyperglycemia, J. Auton. Nerv. Syst., 1987, vol. 20, no. 3, pp. 221–231.
3. Ashmarin, I.P. and Koroleva, S.V., Negative and Positive Emotions. Neurochemical Mechanisms of Effect on Pathological Processes, Patogenez, 2004, no. 1, pp. 30–38.
4. Bagdy, G., Calogero, A.E., Szemeredi, K., et al., Beta-Endorphin Responses to Different Serotonin Agonists: Involvement of Corticotropin-Releasing Hormone, Vasopressin and Direct Pituitary Action, Brain Res., 1990, vol. 537, nos. 1–2, pp. 227–232.
5. Bankson, G.M. and Cunningham, K.A., 3,4-Methylene-dioxymethamphetamine (MDMA) as a Unique Model of Serotonin Receptor Function and Serotonin-Dophamine Interactions, J. Pharmacol. Exp. Ther., 2001, vol. 297, no. 3, pp. 846–852.